blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2654731

EP2654731 - SOLID RETARD FORMULATIONS BASED ON SOLID DISPERSIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.06.2017
Database last updated on 25.09.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
AbbVie Deutschland GmbH & Co. KG
Mainzer Strasse 81
65189 Wiesbaden / DE
[2016/10]
Former [2013/44]For all designated states
Abbott GmbH & Co. KG
Max-Planck-Ring 2
65205 Wiesbaden / DE
Inventor(s)01 / BERNDL, Gunther
Apfelgasse 13
67098 Bad Dürkheim / DE
02 / WEIS, Juergen
Am Lindenbaum 21
60433 Frankfurt/Main / DE
03 / GRANZOW, Dietrich
Roseggerstr. 3
67065 Ludwigshafen / DE
04 / LIEPOLD, Bernd
Birkenweg 44
69221 Dossenheim / DE
05 / LANDER, Ute
Ratsteig 1
67814 Dannenfels / DE
06 / WESTEDT, Ulrich
Weinheimer Str. 2
69198 Schriesheim / DE
 [2013/44]
Representative(s)Reitstötter Kinzebach
Patentanwälte
Sternwartstraße 4
81679 München / DE
[N/P]
Former [2016/30]Reitstötter Kinzebach
Patentanwälte
Sternwartstrasse 4
81679 München / DE
Former [2013/44]Reitstötter - Kinzebach
Patentanwälte Sternwartstrasse 4
81679 München / DE
Application number, filing date11808863.222.12.2011
[2016/30]
WO2011EP73850
Priority number, dateEP2010019693623.12.2010         Original published format: EP 10196936
[2013/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012085236
Date:28.06.2012
Language:EN
[2012/26]
Type: A1 Application with search report 
No.:EP2654731
Date:30.10.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 28.06.2012 takes the place of the publication of the European patent application.
[2013/44]
Type: B1 Patent specification 
No.:EP2654731
Date:27.07.2016
Language:EN
[2016/30]
Search report(s)International search report - published on:EP28.06.2012
ClassificationIPC:A61K9/20, A61K47/32, A61K47/34
[2013/44]
CPC:
A61K9/146 (EP,US); A61K47/34 (US); A61K31/167 (US);
A61K31/192 (US); A61K31/216 (US); A61K47/32 (US);
A61K9/00 (US); A61K9/2095 (EP,US); A61K9/2027 (EP,US);
A61K9/2031 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/44]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:FESTE VERZÖGERUNGSFORMULIERUNGEN BASIEREND AUF FESTDISPERGIERUNGEN[2015/47]
English:SOLID RETARD FORMULATIONS BASED ON SOLID DISPERSIONS[2013/44]
French:FORMULATIONS SOLIDES À LIBÉRATION PROLONGÉE POUR DISPERSIONS SOLIDES[2015/47]
Former [2013/44]FESTE VERZÖGERUNGSFORMULIERUNGEN AUF DER BASIS VON FESTEN DISPERSIONEN
Former [2013/44]FORMULATIONS RETARD SOLIDES À BASE DE DISPERSIONS SOLIDES
Entry into regional phase18.06.2013National basic fee paid 
18.06.2013Designation fee(s) paid 
18.06.2013Examination fee paid 
Examination procedure23.10.2012Request for preliminary examination filed
International Preliminary Examining Authority: EP
18.06.2013Examination requested  [2013/44]
07.07.2014Despatch of a communication from the examining division (Time limit: M04)
17.11.2014Reply to a communication from the examining division
02.11.2015Communication of intention to grant the patent
14.03.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
14.03.2016Fee for grant paid
14.03.2016Fee for publishing/printing paid
08.06.2016Communication of intention to grant the patent
15.06.2016Fee for grant paid
15.06.2016Fee for publishing/printing paid
15.06.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.07.2014
Opposition(s)02.05.2017No opposition filed within time limit [2017/27]
Fees paidRenewal fee
23.12.2013Renewal fee patent year 03
05.12.2014Renewal fee patent year 04
07.12.2015Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU22.12.2011
AL27.07.2016
CY27.07.2016
CZ27.07.2016
EE27.07.2016
FI27.07.2016
HR27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
MK27.07.2016
RS27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
BG27.10.2016
NO27.10.2016
IS27.11.2016
LU22.12.2016
MT22.12.2016
[2018/46]
Former [2018/43]HU22.12.2011
CY27.07.2016
CZ27.07.2016
EE27.07.2016
FI27.07.2016
HR27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
MK27.07.2016
RS27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
BG27.10.2016
NO27.10.2016
IS27.11.2016
LU22.12.2016
MT22.12.2016
Former [2018/28]HU22.12.2011
CY27.07.2016
CZ27.07.2016
EE27.07.2016
FI27.07.2016
HR27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
MK27.07.2016
RS27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
BG27.10.2016
NO27.10.2016
IS27.11.2016
LU22.12.2016
Former [2017/49]CZ27.07.2016
EE27.07.2016
FI27.07.2016
HR27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
RS27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
BG27.10.2016
NO27.10.2016
IS27.11.2016
LU22.12.2016
Former [2017/45]CZ27.07.2016
EE27.07.2016
FI27.07.2016
HR27.07.2016
LT27.07.2016
LV27.07.2016
MC27.07.2016
RS27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
BG27.10.2016
NO27.10.2016
IS27.11.2016
Former [2017/37]CZ27.07.2016
EE27.07.2016
FI27.07.2016
HR27.07.2016
LT27.07.2016
LV27.07.2016
RS27.07.2016
SI27.07.2016
SK27.07.2016
SM27.07.2016
BG27.10.2016
NO27.10.2016
IS27.11.2016
Former [2017/32]CZ27.07.2016
EE27.07.2016
FI27.07.2016
HR27.07.2016
LT27.07.2016
LV27.07.2016
RS27.07.2016
SK27.07.2016
SM27.07.2016
BG27.10.2016
NO27.10.2016
IS27.11.2016
Former [2017/20]FI27.07.2016
HR27.07.2016
LT27.07.2016
LV27.07.2016
RS27.07.2016
NO27.10.2016
IS27.11.2016
Former [2017/10]FI27.07.2016
HR27.07.2016
LT27.07.2016
RS27.07.2016
NO27.10.2016
IS27.11.2016
Former [2017/09]FI27.07.2016
LT27.07.2016
NO27.10.2016
Former [2017/07]LT27.07.2016
Cited inInternational search[I]US4769236  (PANOZ DONALD E [IE], et al) [I] 1-10 * column 1, line 54 - column 2, line 2; claim 1 *;
 [I]WO2009050289  (ABBOTT GMBH & CO KG [DE], et al) [I] 1-10 * page 1, line 23 - page 2, line 20; claims 1-12 *;
 [I]WO2010000740  (ABBOTT GMBH & CO KG [DE], et al) [I] 1-10 * page 2, line 15 - line 41; claim - * * page 5, line 4 - line 7 * * page 11, line 23 - page 12, line 21 *;
 [I]WO2010130728  (BASF SE [DE], et al) [I] 1-10 * page 1, line 20 - page 4, line 19; claim 1 *;
 [A]  - SERAJUDDIN ET AL, "SOLID DISPERSION OF POORLY WATER-SOUBLE DRUGS: EARLY PROMISES, SUBSEQUENT PROBLEMS, AND RECENT BREAKTHROUGHS", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, (19991001), vol. 88, no. 10, doi:DOI:10.1021/JS980403L, ISSN 0022-3549, pages 1058 - 1066, XP000851882 [A] 1-10 * abstract *

DOI:   http://dx.doi.org/10.1021/js980403l
by applicantDE1077430
 EP0219048
 EP0240904
 EP0240906
 EP0544144
 WO9625151
 WO0134119
 WO2007115381
    - JANSSENS ET AL., EUR J PHARM SCI, (2007), vol. 30, pages 288 - 294
    - SIX ET AL., J PHARM SCI, (2004), vol. 93, no. 1, pages 124 - 131
    - J. M. HARRIS, Chemistry: Biotechnical and Biomedical Applications, PLENUM PRESS
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.